The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valganciclovir Tablets Market Research Report 2025
Synopsis
Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS.
The global Valganciclovir Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valganciclovir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valganciclovir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valganciclovir Tablets include Ajanta Pharma USA Inc., Dr. Reddy’s Laboratories Inc., Cheplapharm Arzneimittel GmbH, Extrovis AG, Pharmathen SA, Viatris, Hoffmann-La Roche, Patheon and Yifan Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valganciclovir Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valganciclovir Tablets.
Report Scope
The Valganciclovir Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valganciclovir Tablets market comprehensively. Regional market sizes, concerning products by Type, by Sales Channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valganciclovir Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channels, and by regions.
Market Segmentation
By Company
Ajanta Pharma USA Inc.
Dr. Reddy’s Laboratories Inc.
Cheplapharm Arzneimittel GmbH
Extrovis AG
Pharmathen SA
Viatris
Hoffmann-La Roche
Patheon
Yifan Pharmaceutical
Hubei Gedian Humanwell Pharmaceutical
Segment by Type
450mg
900mg
Segment by Sales Channels
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sales Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valganciclovir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valganciclovir Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valganciclovir hydrochloride is an antiviral prescription medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of cytomegalovirus retinitis (CMV retinitis) in adults with AIDS.
The global Valganciclovir Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valganciclovir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valganciclovir Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valganciclovir Tablets include Ajanta Pharma USA Inc., Dr. Reddy’s Laboratories Inc., Cheplapharm Arzneimittel GmbH, Extrovis AG, Pharmathen SA, Viatris, Hoffmann-La Roche, Patheon and Yifan Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valganciclovir Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valganciclovir Tablets.
Report Scope
The Valganciclovir Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valganciclovir Tablets market comprehensively. Regional market sizes, concerning products by Type, by Sales Channels, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valganciclovir Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Sales Channels, and by regions.
Market Segmentation
By Company
Ajanta Pharma USA Inc.
Dr. Reddy’s Laboratories Inc.
Cheplapharm Arzneimittel GmbH
Extrovis AG
Pharmathen SA
Viatris
Hoffmann-La Roche
Patheon
Yifan Pharmaceutical
Hubei Gedian Humanwell Pharmaceutical
Segment by Type
450mg
900mg
Segment by Sales Channels
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Sales Channels, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valganciclovir Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valganciclovir Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Sales Channels, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valganciclovir Tablets Market Overview
1.1 Product Overview and Scope of Valganciclovir Tablets
1.2 Valganciclovir Tablets Segment by Type
1.2.1 Global Valganciclovir Tablets Market Value Comparison by Type (2024-2030)
1.2.2 450mg
1.2.3 900mg
1.3 Valganciclovir Tablets Segment by Sales Channels
1.3.1 Global Valganciclovir Tablets Market Value by Sales Channels: (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Valganciclovir Tablets Market Size Estimates and Forecasts
1.4.1 Global Valganciclovir Tablets Revenue 2019-2030
1.4.2 Global Valganciclovir Tablets Sales 2019-2030
1.4.3 Global Valganciclovir Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valganciclovir Tablets Market Competition by Manufacturers
2.1 Global Valganciclovir Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valganciclovir Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valganciclovir Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Valganciclovir Tablets Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valganciclovir Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valganciclovir Tablets, Product Type & Application
2.7 Valganciclovir Tablets Market Competitive Situation and Trends
2.7.1 Valganciclovir Tablets Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valganciclovir Tablets Players Market Share by Revenue
2.7.3 Global Valganciclovir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valganciclovir Tablets Retrospective Market Scenario by Region
3.1 Global Valganciclovir Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valganciclovir Tablets Global Valganciclovir Tablets Sales by Region: 2019-2030
3.2.1 Global Valganciclovir Tablets Sales by Region: 2019-2024
3.2.2 Global Valganciclovir Tablets Sales by Region: 2025-2030
3.3 Global Valganciclovir Tablets Global Valganciclovir Tablets Revenue by Region: 2019-2030
3.3.1 Global Valganciclovir Tablets Revenue by Region: 2019-2024
3.3.2 Global Valganciclovir Tablets Revenue by Region: 2025-2030
3.4 North America Valganciclovir Tablets Market Facts & Figures by Country
3.4.1 North America Valganciclovir Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valganciclovir Tablets Sales by Country (2019-2030)
3.4.3 North America Valganciclovir Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Valganciclovir Tablets Market Facts & Figures by Country
3.5.1 Europe Valganciclovir Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valganciclovir Tablets Sales by Country (2019-2030)
3.5.3 Europe Valganciclovir Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Valganciclovir Tablets Market Facts & Figures by Country
3.6.1 Asia Pacific Valganciclovir Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valganciclovir Tablets Sales by Country (2019-2030)
3.6.3 Asia Pacific Valganciclovir Tablets Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Valganciclovir Tablets Market Facts & Figures by Country
3.7.1 Latin America Valganciclovir Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valganciclovir Tablets Sales by Country (2019-2030)
3.7.3 Latin America Valganciclovir Tablets Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Valganciclovir Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Valganciclovir Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valganciclovir Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valganciclovir Tablets Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valganciclovir Tablets Sales by Type (2019-2030)
4.1.1 Global Valganciclovir Tablets Sales by Type (2019-2024)
4.1.2 Global Valganciclovir Tablets Sales by Type (2025-2030)
4.1.3 Global Valganciclovir Tablets Sales Market Share by Type (2019-2030)
4.2 Global Valganciclovir Tablets Revenue by Type (2019-2030)
4.2.1 Global Valganciclovir Tablets Revenue by Type (2019-2024)
4.2.2 Global Valganciclovir Tablets Revenue by Type (2025-2030)
4.2.3 Global Valganciclovir Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Valganciclovir Tablets Price by Type (2019-2030)
5 Segment by Sales Channels
5.1 Global Valganciclovir Tablets Sales by Sales Channels (2019-2030)
5.1.1 Global Valganciclovir Tablets Sales by Sales Channels (2019-2024)
5.1.2 Global Valganciclovir Tablets Sales by Sales Channels (2025-2030)
5.1.3 Global Valganciclovir Tablets Sales Market Share by Sales Channels (2019-2030)
5.2 Global Valganciclovir Tablets Revenue by Sales Channels (2019-2030)
5.2.1 Global Valganciclovir Tablets Revenue by Sales Channels (2019-2024)
5.2.2 Global Valganciclovir Tablets Revenue by Sales Channels (2025-2030)
5.2.3 Global Valganciclovir Tablets Revenue Market Share by Sales Channels (2019-2030)
5.3 Global Valganciclovir Tablets Price by Sales Channels (2019-2030)
6 Key Companies Profiled
6.1 Ajanta Pharma USA Inc.
6.1.1 Ajanta Pharma USA Inc. Corporation Information
6.1.2 Ajanta Pharma USA Inc. Description and Business Overview
6.1.3 Ajanta Pharma USA Inc. Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ajanta Pharma USA Inc. Valganciclovir Tablets Product Portfolio
6.1.5 Ajanta Pharma USA Inc. Recent Developments/Updates
6.2 Dr. Reddy’s Laboratories Inc.
6.2.1 Dr. Reddy’s Laboratories Inc. Corporation Information
6.2.2 Dr. Reddy’s Laboratories Inc. Description and Business Overview
6.2.3 Dr. Reddy’s Laboratories Inc. Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Dr. Reddy’s Laboratories Inc. Valganciclovir Tablets Product Portfolio
6.2.5 Dr. Reddy’s Laboratories Inc. Recent Developments/Updates
6.3 Cheplapharm Arzneimittel GmbH
6.3.1 Cheplapharm Arzneimittel GmbH Corporation Information
6.3.2 Cheplapharm Arzneimittel GmbH Description and Business Overview
6.3.3 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product Portfolio
6.3.5 Cheplapharm Arzneimittel GmbH Recent Developments/Updates
6.4 Extrovis AG
6.4.1 Extrovis AG Corporation Information
6.4.2 Extrovis AG Description and Business Overview
6.4.3 Extrovis AG Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Extrovis AG Valganciclovir Tablets Product Portfolio
6.4.5 Extrovis AG Recent Developments/Updates
6.5 Pharmathen SA
6.5.1 Pharmathen SA Corporation Information
6.5.2 Pharmathen SA Description and Business Overview
6.5.3 Pharmathen SA Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pharmathen SA Valganciclovir Tablets Product Portfolio
6.5.5 Pharmathen SA Recent Developments/Updates
6.6 Viatris
6.6.1 Viatris Corporation Information
6.6.2 Viatris Description and Business Overview
6.6.3 Viatris Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Viatris Valganciclovir Tablets Product Portfolio
6.6.5 Viatris Recent Developments/Updates
6.7 Hoffmann-La Roche
6.6.1 Hoffmann-La Roche Corporation Information
6.6.2 Hoffmann-La Roche Description and Business Overview
6.6.3 Hoffmann-La Roche Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hoffmann-La Roche Valganciclovir Tablets Product Portfolio
6.7.5 Hoffmann-La Roche Recent Developments/Updates
6.8 Patheon
6.8.1 Patheon Corporation Information
6.8.2 Patheon Description and Business Overview
6.8.3 Patheon Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Patheon Valganciclovir Tablets Product Portfolio
6.8.5 Patheon Recent Developments/Updates
6.9 Yifan Pharmaceutical
6.9.1 Yifan Pharmaceutical Corporation Information
6.9.2 Yifan Pharmaceutical Description and Business Overview
6.9.3 Yifan Pharmaceutical Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Yifan Pharmaceutical Valganciclovir Tablets Product Portfolio
6.9.5 Yifan Pharmaceutical Recent Developments/Updates
6.10 Hubei Gedian Humanwell Pharmaceutical
6.10.1 Hubei Gedian Humanwell Pharmaceutical Corporation Information
6.10.2 Hubei Gedian Humanwell Pharmaceutical Description and Business Overview
6.10.3 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product Portfolio
6.10.5 Hubei Gedian Humanwell Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valganciclovir Tablets Industry Chain Analysis
7.2 Valganciclovir Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valganciclovir Tablets Production Mode & Process
7.4 Valganciclovir Tablets Sales and Marketing
7.4.1 Valganciclovir Tablets Sales Channels
7.4.2 Valganciclovir Tablets Distributors
7.5 Valganciclovir Tablets Customers
8 Valganciclovir Tablets Market Dynamics
8.1 Valganciclovir Tablets Industry Trends
8.2 Valganciclovir Tablets Market Drivers
8.3 Valganciclovir Tablets Market Challenges
8.4 Valganciclovir Tablets Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Valganciclovir Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Valganciclovir Tablets Market Value Comparison by Sales Channels (2024-2030) & (US$ Million)
Table 3. Global Valganciclovir Tablets Market Competitive Situation by Manufacturers in 2023
Table 4. Global Valganciclovir Tablets Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Valganciclovir Tablets Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Valganciclovir Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Valganciclovir Tablets Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Valganciclovir Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Valganciclovir Tablets, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Valganciclovir Tablets, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Valganciclovir Tablets, Product Type & Application
Table 12. Global Key Manufacturers of Valganciclovir Tablets, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Valganciclovir Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valganciclovir Tablets as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Valganciclovir Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Valganciclovir Tablets Sales by Region (2019-2024) & (K Units)
Table 18. Global Valganciclovir Tablets Sales Market Share by Region (2019-2024)
Table 19. Global Valganciclovir Tablets Sales by Region (2025-2030) & (K Units)
Table 20. Global Valganciclovir Tablets Sales Market Share by Region (2025-2030)
Table 21. Global Valganciclovir Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Valganciclovir Tablets Revenue Market Share by Region (2019-2024)
Table 23. Global Valganciclovir Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Valganciclovir Tablets Revenue Market Share by Region (2025-2030)
Table 25. North America Valganciclovir Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Valganciclovir Tablets Sales by Country (2019-2024) & (K Units)
Table 27. North America Valganciclovir Tablets Sales by Country (2025-2030) & (K Units)
Table 28. North America Valganciclovir Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Valganciclovir Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Valganciclovir Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Valganciclovir Tablets Sales by Country (2019-2024) & (K Units)
Table 32. Europe Valganciclovir Tablets Sales by Country (2025-2030) & (K Units)
Table 33. Europe Valganciclovir Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Valganciclovir Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Valganciclovir Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Valganciclovir Tablets Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Valganciclovir Tablets Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Valganciclovir Tablets Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Valganciclovir Tablets Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Valganciclovir Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Valganciclovir Tablets Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Valganciclovir Tablets Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Valganciclovir Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Valganciclovir Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Valganciclovir Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Valganciclovir Tablets Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Valganciclovir Tablets Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Valganciclovir Tablets Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Valganciclovir Tablets Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Valganciclovir Tablets Sales (K Units) by Type (2019-2024)
Table 51. Global Valganciclovir Tablets Sales (K Units) by Type (2025-2030)
Table 52. Global Valganciclovir Tablets Sales Market Share by Type (2019-2024)
Table 53. Global Valganciclovir Tablets Sales Market Share by Type (2025-2030)
Table 54. Global Valganciclovir Tablets Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Valganciclovir Tablets Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Valganciclovir Tablets Revenue Market Share by Type (2019-2024)
Table 57. Global Valganciclovir Tablets Revenue Market Share by Type (2025-2030)
Table 58. Global Valganciclovir Tablets Price (US$/Unit) by Type (2019-2024)
Table 59. Global Valganciclovir Tablets Price (US$/Unit) by Type (2025-2030)
Table 60. Global Valganciclovir Tablets Sales (K Units) by Sales Channels (2019-2024)
Table 61. Global Valganciclovir Tablets Sales (K Units) by Sales Channels (2025-2030)
Table 62. Global Valganciclovir Tablets Sales Market Share by Sales Channels (2019-2024)
Table 63. Global Valganciclovir Tablets Sales Market Share by Sales Channels (2025-2030)
Table 64. Global Valganciclovir Tablets Revenue (US$ Million) by Sales Channels (2019-2024)
Table 65. Global Valganciclovir Tablets Revenue (US$ Million) by Sales Channels (2025-2030)
Table 66. Global Valganciclovir Tablets Revenue Market Share by Sales Channels (2019-2024)
Table 67. Global Valganciclovir Tablets Revenue Market Share by Sales Channels (2025-2030)
Table 68. Global Valganciclovir Tablets Price (US$/Unit) by Sales Channels (2019-2024)
Table 69. Global Valganciclovir Tablets Price (US$/Unit) by Sales Channels (2025-2030)
Table 70. Ajanta Pharma USA Inc. Corporation Information
Table 71. Ajanta Pharma USA Inc. Description and Business Overview
Table 72. Ajanta Pharma USA Inc. Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Ajanta Pharma USA Inc. Valganciclovir Tablets Product
Table 74. Ajanta Pharma USA Inc. Recent Developments/Updates
Table 75. Dr. Reddy’s Laboratories Inc. Corporation Information
Table 76. Dr. Reddy’s Laboratories Inc. Description and Business Overview
Table 77. Dr. Reddy’s Laboratories Inc. Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Dr. Reddy’s Laboratories Inc. Valganciclovir Tablets Product
Table 79. Dr. Reddy’s Laboratories Inc. Recent Developments/Updates
Table 80. Cheplapharm Arzneimittel GmbH Corporation Information
Table 81. Cheplapharm Arzneimittel GmbH Description and Business Overview
Table 82. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Cheplapharm Arzneimittel GmbH Valganciclovir Tablets Product
Table 84. Cheplapharm Arzneimittel GmbH Recent Developments/Updates
Table 85. Extrovis AG Corporation Information
Table 86. Extrovis AG Description and Business Overview
Table 87. Extrovis AG Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Extrovis AG Valganciclovir Tablets Product
Table 89. Extrovis AG Recent Developments/Updates
Table 90. Pharmathen SA Corporation Information
Table 91. Pharmathen SA Description and Business Overview
Table 92. Pharmathen SA Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Pharmathen SA Valganciclovir Tablets Product
Table 94. Pharmathen SA Recent Developments/Updates
Table 95. Viatris Corporation Information
Table 96. Viatris Description and Business Overview
Table 97. Viatris Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Viatris Valganciclovir Tablets Product
Table 99. Viatris Recent Developments/Updates
Table 100. Hoffmann-La Roche Corporation Information
Table 101. Hoffmann-La Roche Description and Business Overview
Table 102. Hoffmann-La Roche Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Hoffmann-La Roche Valganciclovir Tablets Product
Table 104. Hoffmann-La Roche Recent Developments/Updates
Table 105. Patheon Corporation Information
Table 106. Patheon Description and Business Overview
Table 107. Patheon Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Patheon Valganciclovir Tablets Product
Table 109. Patheon Recent Developments/Updates
Table 110. Yifan Pharmaceutical Corporation Information
Table 111. Yifan Pharmaceutical Description and Business Overview
Table 112. Yifan Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Yifan Pharmaceutical Valganciclovir Tablets Product
Table 114. Yifan Pharmaceutical Recent Developments/Updates
Table 115. Hubei Gedian Humanwell Pharmaceutical Corporation Information
Table 116. Hubei Gedian Humanwell Pharmaceutical Description and Business Overview
Table 117. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Hubei Gedian Humanwell Pharmaceutical Valganciclovir Tablets Product
Table 119. Hubei Gedian Humanwell Pharmaceutical Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Valganciclovir Tablets Distributors List
Table 123. Valganciclovir Tablets Customers List
Table 124. Valganciclovir Tablets Market Trends
Table 125. Valganciclovir Tablets Market Drivers
Table 126. Valganciclovir Tablets Market Challenges
Table 127. Valganciclovir Tablets Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Valganciclovir Tablets
Figure 2. Global Valganciclovir Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Valganciclovir Tablets Market Share by Type in 2023 & 2030
Figure 4. 450mg Product Picture
Figure 5. 900mg Product Picture
Figure 6. Global Valganciclovir Tablets Market Value Comparison by Sales Channels (2024-2030) & (US$ Million)
Figure 7. Global Valganciclovir Tablets Market Share by Sales Channels in 2023 & 2030
Figure 8. Online Sales
Figure 9. Offline Sales
Figure 10. Global Valganciclovir Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Valganciclovir Tablets Market Size (2019-2030) & (US$ Million)
Figure 12. Global Valganciclovir Tablets Sales (2019-2030) & (K Units)
Figure 13. Global Valganciclovir Tablets Average Price (US$/Unit) & (2019-2030)
Figure 14. Valganciclovir Tablets Report Years Considered
Figure 15. Valganciclovir Tablets Sales Share by Manufacturers in 2023
Figure 16. Global Valganciclovir Tablets Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Valganciclovir Tablets Players: Market Share by Revenue in 2023
Figure 18. Valganciclovir Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Valganciclovir Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Valganciclovir Tablets Sales Market Share by Country (2019-2030)
Figure 21. North America Valganciclovir Tablets Revenue Market Share by Country (2019-2030)
Figure 22. United States Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Valganciclovir Tablets Sales Market Share by Country (2019-2030)
Figure 25. Europe Valganciclovir Tablets Revenue Market Share by Country (2019-2030)
Figure 26. Germany Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Valganciclovir Tablets Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Valganciclovir Tablets Revenue Market Share by Region (2019-2030)
Figure 33. China Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Valganciclovir Tablets Sales Market Share by Country (2019-2030)
Figure 41. Latin America Valganciclovir Tablets Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Valganciclovir Tablets Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Valganciclovir Tablets Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Valganciclovir Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Valganciclovir Tablets by Type (2019-2030)
Figure 52. Global Revenue Market Share of Valganciclovir Tablets by Type (2019-2030)
Figure 53. Global Valganciclovir Tablets Price (US$/Unit) by Type (2019-2030)
Figure 54. Global Sales Market Share of Valganciclovir Tablets by Sales Channels (2019-2030)
Figure 55. Global Revenue Market Share of Valganciclovir Tablets by Sales Channels (2019-2030)
Figure 56. Global Valganciclovir Tablets Price (US$/Unit) by Sales Channels (2019-2030)
Figure 57. Valganciclovir Tablets Value Chain
Figure 58. Valganciclovir Tablets Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
